Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study

被引:452
作者
Langan, S. M. [1 ]
Smeeth, L. [2 ]
Hubbard, R. [3 ]
Fleming, K. M. [3 ]
Smith, C. J. P. [3 ]
West, J. [3 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Ctr Evidence Based Dermatol, Nottingham NG7 2UH, England
[2] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Ctr Populat Studies Noncommun Dis Epidemiol, London WC1, England
[3] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2UH, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2008年 / 337卷 / 7662期
基金
英国惠康基金;
关键词
D O I
10.1136/bmj.a180
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the incidence of and mortality from bullous pemphigoid and pemphigus vulgaris in the United kingdom. Design Retrospective historical cohort study. Setting Computerised medical records from the health improvement network, a large population based UK general practice database. Participants Patients with pemphigus vulgaris and bullous pemphigoid diagnostic codes and age, sex, and practice matched controls. Main outcome measures incidence and mortality compared with the control population by calendar period, age group, sex, geographical region, and degree of social deprivation. Results 869 people with bullous pemphigoid and 138 people with pemphigus vulgaris were identified. The median age at presentation for bullous pemphigoid was 80 (range 23-102) years, and 534 (61%) patients were female. The median age at presentation for pemphigus vulgaris was 71 (21-102) years, and 91 (66%) patients were female. Incidences of bullous pemphigoid and pemphigus vulgaris were 4.3 (95% confidence interval 4.0 to 4.6) and 0.7 (0.6 to 0.8) per 100 000 person years. The incidence of bullous pemphigoid increased overtime; the average yearly increase was 17% (incidence rate ratio=1.2, 95% confidence interval 1.1 to 1.2). An average yearly increase in incidence of pemphigus vulgaris of 11% (incidence rate ratio=1.1, 1.0 to 1.2) occurred. The risk of death for patients with bullous pemphigoid was twice as, great as for controls (adjusted hazard ratio=2.3, 95% confidence interval 2.0 to 2.7). For pemphigus vulgaris, the risk of death was three times greater than for controls (adjusted hazard ratio=3.3, 2.2 to 5.2). Conclusions Incidences of bullous pemphigoid and pemphigus vulgaris are increasing. The reasons for the changes in incidence are not clearly understood but have implications for identifying causative factors. Both disorders are associated with a high risk of death. Previous estimates may have underestimated the risk of death associated with these diseases.
引用
收藏
页码:160 / 163
页数:6
相关论文
共 20 条
[1]   BULLOUS DISEASES IN MALAYSIA - EPIDEMIOLOGY AND NATURAL-HISTORY [J].
ADAM, BA .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1992, 31 (01) :42-45
[2]   Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study [J].
Bath-Hextall, Fiona ;
Leonardi-Bee, Jo ;
Smith, Chris ;
Meal, Andy ;
Hubbard, Richard .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (09) :2105-2108
[3]   Mortality rate of bullous pemphigoid in a US medical center [J].
Colbert, RL ;
Allen, DM ;
Eastwood, D ;
Fairley, JA .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (05) :1091-1095
[4]   Bullous pemphigoid triggered by influenza vaccination?: Ecological study in Galicia, Spain [J].
Garcia-Doval, I. ;
Mayo, E. ;
Farina, J. Nogueira ;
Cruces, M. J. .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 155 (04) :820-823
[5]  
GELLIS S, 1941, ARCH DERMATOL SYPHIO, P44
[6]   Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland [J].
Gudi, VS ;
White, MI ;
Cruickshank, N ;
Herriot, R ;
Edwards, SL ;
Nimmo, F ;
Ormerod, AD .
BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (02) :424-427
[7]  
HIETANEN J, 1982, ACTA DERM-VENEREOL, V62, P491
[8]   Response to: Mortality rate of bullous pemphigoid in a US medical center [J].
Joly, P ;
Benichou, J ;
Saiag, P ;
Bernard, P ;
Roujeau, JC .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (03) :664-665
[9]   A comparison of oral and topical corticosteroids in patients with bullous pemphigoid [J].
Joly, P ;
Roujeau, JC ;
Benichou, J ;
Picard, C ;
Dreno, B ;
Delaporte, E ;
Vaillant, L ;
D'Incan, M ;
Plantin, P ;
Bedane, C ;
Young, P ;
Bernard, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (05) :321-327
[10]   Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence [J].
Jung, M ;
Kippes, W ;
Messer, G ;
Zillikens, D ;
Rzany, B .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (02) :266-268